Skip to main content
    D

    Danaher Corporation (DHR)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $230.11
    -2.91 (-1.25%)

    Market Cap: $163.94B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Danaher Corporation (DHR) Earnings: Report Dates and Results

    Updated Oct 21, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Danaher (DHR) is expected to report earnings on Jan 26, 2027. In the quarter ended Sep 30, 2026, Danaher reported EPS of $2.11, above the $1.92 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    98%(39/40)
    Avg Surprise
    +8.68%
    Streak
    7 Q

    Upcoming Estimates

    Reports Jan 26, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$2.50
    Range$2.42 - $2.63
    23 analysts
    Revenue Consensus
    $7.57B
    Range$7.27B - $7.92B
    22 analysts
    Reports Apr 19, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$2.24
    Range$2.15 - $2.28
    13 analysts
    EPS Revisions
    7
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$2.23+0.3%
    60d ago$2.24+0.0%
    30d ago$2.24+0.1%
    7d ago$2.24+0.1%
    Current$2.24
    Revenue Consensus
    $6.63B
    Range$6.50B - $6.73B
    10 analysts

    Next Report

    DHR has an expected report date of Jan 26, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 12.1% above the $2.23 reported for the quarter ended Dec 31, 2025.

    DHR Earnings Call

    The latest DHR earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, DHR beat 39 and missed 1. Revenue for the quarter ended Sep 30, 2026 was $6.55B, up 8.3% from $6.05B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$2.11$1.92$1.90 - $1.99+9.90%Beat+11.6%20N/AOct 21, 2026$6.55B
    Jun 30, 2026$1.94$1.84$1.83 - $1.86+5.43%Beat+7.8%52 up, 0 downJul 21, 2026$6.26B
    Mar 31, 2026$2.06$1.94$1.91 - $1.96+6.19%Beat+9.6%201 up, 2 downApr 21, 2026$5.95B
    Dec 31, 2025$2.23$2.19$2.14 - $2.24+1.83%Beat+4.2%113 up, 0 downJan 28, 2026$6.84B
    Sep 30, 2025$1.89$1.72$1.69 - $1.78+9.88%Beat+10.5%193 up, 2 downOct 21, 2025$6.05B
    Jun 30, 2025$1.80$1.64$1.62 - $1.66+9.76%Beat+4.7%210 up, 1 downJul 22, 2025$5.94B
    Mar 31, 2025$1.88$1.64$1.56 - $1.97+14.63%Beat-2.1%223 up, 2 downApr 22, 2025$5.74B
    Dec 31, 2024$2.14$2.16$2.11 - $2.22-0.93%Miss+2.4%225 up, 2 downJan 29, 2025$6.54B
    Sep 30, 2024$1.71$1.57$1.53 - $1.70+8.92%Beat-15.3%225 up, 0 downOct 22, 2024$5.80B
    Jun 30, 2024$1.72$1.57$1.55 - $1.64+9.55%Beat-16.1%201 up, 2 downJul 23, 2024$5.74B
    Mar 31, 2024$1.92$1.71N/A+12.28%Beat-18.6%202 up, 1 downApr 23, 2024$5.80B
    Dec 31, 2023$2.09$1.91$1.66 - $1.98+9.42%Beat-27.2%205 up, 0 downJan 30, 2024$6.41B
    Sep 30, 2023$2.02$1.88$1.54 - $2.02+7.45%Beat-21.1%192 up, 0 downOct 24, 2023$5.62B
    Jun 30, 2023$2.05$2.02N/A+1.49%Beat-25.7%211 up, 1 downJul 25, 2023$5.91B
    Mar 31, 2023$2.36$2.26$2.20 - $2.28+4.42%Beat-14.5%201 up, 0 downApr 25, 2023$5.95B
    Dec 31, 2022$2.87$2.55$2.35 - $2.84+12.55%Beat+6.7%219 up, 1 downJan 24, 2023$3.54B
    Sep 30, 2022$2.56$2.25$2.20 - $2.41+13.78%Beat+7.1%204 up, 1 downOct 20, 2022$7.66B
    Jun 30, 2022$2.76$2.34$2.29 - $2.50+17.95%Beat+12.2%180 up, 0 downJul 21, 2022$7.75B
    Mar 31, 2022$2.76$2.66$2.44 - $2.80+3.76%Beat+9.5%183 up, 0 downApr 21, 2022$7.69B
    Dec 31, 2021$2.69$2.54$2.39 - $2.73+5.91%Beat+29.3%198 up, 0 downJan 27, 2022$3.50B
    Sep 30, 2021$2.39$2.15$1.99 - $2.30+11.16%Beat+39.0%18N/AOct 21, 2021$7.23B
    Jun 30, 2021$2.46$2.05$1.97 - $2.15+20.00%Beat+70.8%18N/AJul 22, 2021$7.22B
    Mar 31, 2021$2.52$1.77$1.59 - $2.09+42.37%Beat+140.0%18N/AApr 22, 2021$6.86B
    Dec 31, 2020$2.08$1.88$1.77 - $2.03+10.64%Beat+62.5%19N/AJan 28, 2021$6.76B
    Sep 30, 2020$1.72$1.36$1.30 - $1.45+26.47%Beat+48.3%16N/AOct 22, 2020$5.88B
    Jun 30, 2020$1.44$1.09$0.90 - $1.25+32.11%Beat+21.0%15N/AJul 23, 2020$5.30B
    Mar 31, 2020$1.05$1.02$0.69 - $1.08+2.94%Beat-1.9%11N/AMay 6, 2020$4.34B
    Dec 31, 2019$1.28$1.25$1.24 - $1.28+2.40%Beat0.0%11N/AJan 30, 2020$4.87B
    Sep 30, 2019$1.16$1.15$1.13 - $1.17+0.87%Beat+5.5%15N/AOct 24, 2019$4.38B
    Jun 30, 2019$1.19$1.16$1.14 - $1.18+2.59%Beat+3.5%17N/AJul 18, 2019$4.44B
    Mar 31, 2019$1.07$1.02$0.98 - $1.03+4.90%Beat+8.1%15N/AApr 18, 2019$4.22B
    Dec 31, 2018$1.28$1.27$1.25 - $1.28+0.79%Beat+7.6%18N/AJan 29, 2019$2.52B
    Sep 30, 2018$1.10$1.08$1.05 - $1.10+1.85%Beat+10.0%17N/AOct 18, 2018$4.85B
    Jun 30, 2018$1.15$1.09$1.06 - $1.10+5.50%Beat+16.2%17N/AJul 19, 2018$4.98B
    Mar 31, 2018$0.99$0.94$0.91 - $0.96+5.32%Beat+16.5%16N/AApr 19, 2018$4.70B
    Dec 31, 2017$1.19$1.16$1.14 - $1.18+2.59%Beat+13.3%17N/AJan 30, 2018$2.27B
    Sep 30, 2017$1.00$0.95$0.94 - $0.96+5.26%Beat+14.9%15N/AOct 19, 2017$4.53B
    Jun 30, 2017$0.99$0.97$0.95 - $0.98+2.06%Beat-20.8%16N/AJul 20, 2017$4.51B
    Mar 31, 2017$0.85$0.84N/A+1.19%Beat-21.3%N/AN/AApr 20, 2017$4.21B
    Dec 31, 2016$1.05$1.03N/A+1.94%Beat-17.3%N/AN/AJan 31, 2017$4.58B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $7.80, up 4.1% from the year before. It was $4.25 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$7.80+4.1%
    Dec 31, 2024$7.49-12.1%
    Dec 31, 2023$8.52-22.2%
    Dec 31, 2022$10.95+8.8%
    Dec 31, 2021$10.06+59.9%
    Dec 31, 2020$6.29+33.8%
    Dec 31, 2019$4.70+4.0%
    Dec 31, 2018$4.52+12.2%
    Dec 31, 2017$4.03-5.2%
    Dec 31, 2016$4.25N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,400 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,44411
    2026Q2Jun 30, 20267,50313
    2026Q1Mar 31, 20267,39712
    2025Q4Dec 31, 20257,38512
    2025Q3Sep 30, 20256,61411
    2025Q2Jun 30, 20257,94613
    2025Q1Mar 31, 20257,24613
    2024Q4Dec 31, 20247,00611

    2026Q3 Earnings Call

    Opening remarks

    Rachel Vatnsdal Vice President of Investor Relations Good morning, everyone, and thanks for joining us on the call. With us today are Julie Sawyer Montgomery, our President and Chief Executive Officer, and Matt Gugino, our Executive Vice President and Chief Financial Officer. I'd like to point out that our earnings release, quarterly report on Form 10-Q, the slide presentation supplementing today's call, the reconciliations and other information required by SEC Regulation G relating to any non-GAAP financial measures provided during the call, and a note containing details of historical and anticipated future financial performance are all available in the investors section of our website, www.danaher.com, under the heading Quarterly Earnings. The audio portion of this call will be archived in the investors section of our website later today under the heading Events and Presentations and will remain archived until our next quarterly call. A dial-in replay of this call will also be available until November 4th, 2026. During the presentation, we will describe certain of the more significant factors that impacted year-over-year performance. Our Form 10-Q and the supplemental materials I referenced describe additional factors that impacted year-over-year performance. Unless otherwise noted, all references in these remarks and supplemental materials to company-specific financial metrics relate to results from continuing operations in the third quarter of 2026, and all references to period-to-period increases or decreases in financial metrics are year-over-year. We may also describe certain products and devices that have applications submitted and pending for certain regulatory approvals or are available only in certain markets. During the call, we will make forward-looking statements within the meaning of our federal securities laws, including statements regarding events or developments that we believe or anticipate will or may occur in the future. These forward-looking statements are subject to a number of risks and uncertainties, including those set forth in our SEC filings, and actual results may differ materially from any forward-looking statements that we make today. These forward-looking statements speak only as of the date that they are made, and we do not assume any obligation to update any forward-looking statements except as required by law. With that, I'd like to turn the call over to Julie.

    Julie Sawyer Montgomery President and Chief Executive Officer Thank you, Rachel, and good morning, everyone. Before we get into the quarter, I'd like to share my perspective on Danaher today and the opportunity ahead as I begin this next chapter as CEO. The opportunity for Danaher is straightforward: to become the defining leader in Life Sciences and Diagnostics, a company that unambiguously gains share, delivers sustainable, profitable growth, and helps our customers improve outcomes for patients around the world. The foundation we built at Danaher is strong.

    Frequently Asked Questions About DHR

    When is Danaher's next earnings date?

    Danaher's next earnings report is expected for Jan 26, 2027.

    Did DHR beat earnings estimates last quarter?

    Yes. Danaher reported EPS of $2.11 for the quarter ended Sep 30, 2026, above the $1.92 estimate, a 9.90% surprise.

    What EPS do analysts expect from DHR next quarter?

    The consensus EPS estimate for Danaher for the quarter ending Dec 31, 2026 is $2.50 from 23 analysts, with estimates from $2.42 to $2.63.

    How often does DHR beat earnings estimates?

    Danaher beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +7.09%.